Beata Diomsina1, Pernille Darling Rasmussen2
1Vilnius University Medical Faculty Psychiatric Clinic, Vilnius, Lithuania
2Child and Adolescent Psychiatric Clinic, Holbaek, Denmark
Objective: The aim of this study is to share clinical experience with Aripiprazol (Abilify) in treatment of children and adolescents.
Method: The sample (n=33) consists of children and adolescent patients (age 9-18) in treatment with abilify at the Child and Adolescent Psychiatric Clinic 1 (Roskilde, Denmark) in June 2013. All diagnoses were included and covered severe conduct problems (high impulsivity, aggression, outward reaction, and physical cross-border behavior), high restlessness with ADHD, psychotic and psychosis-like symptoms with autistic disorders, psychosis, and intensive tics with Tourette’s syndrome. The study was conducted as a Cross-sectional study with detailed description of all patients included.